Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic
- PMID: 33293339
- PMCID: PMC7857406
- DOI: 10.1126/science.abe9728
Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spread rapidly in Manaus, the capital of Amazonas state in northern Brazil. The attack rate there is an estimate of the final size of the largely unmitigated epidemic that occurred in Manaus. We use a convenience sample of blood donors to show that by June 2020, 1 month after the epidemic peak in Manaus, 44% of the population had detectable immunoglobulin G (IgG) antibodies. Correcting for cases without a detectable antibody response and for antibody waning, we estimate a 66% attack rate in June, rising to 76% in October. This is higher than in São Paulo, in southeastern Brazil, where the estimated attack rate in October was 29%. These results confirm that when poorly controlled, COVID-19 can infect a large proportion of the population, causing high mortality.
Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.
Figures


Comment in
-
Herd immunity by infection is not an option.Science. 2021 Jan 15;371(6526):230-231. doi: 10.1126/science.abf7921. Science. 2021. PMID: 33446540 No abstract available.
Similar articles
-
High anti-SARS-CoV-2 antibody seroconversion rates before the second wave in Manaus, Brazil, and the protective effect of social behaviour measures: results from the prospective DETECTCoV-19 cohort.Lancet Glob Health. 2021 Nov;9(11):e1508-e1516. doi: 10.1016/S2214-109X(21)00355-7. Lancet Glob Health. 2021. PMID: 34678195 Free PMC article.
-
Dynamics of anti-SARS-CoV-2 IgG antibodies post-COVID-19 in a Brazilian Amazon population.BMC Infect Dis. 2021 May 15;21(1):443. doi: 10.1186/s12879-021-06156-x. BMC Infect Dis. 2021. PMID: 33992073 Free PMC article.
-
SARS-CoV-2 antibody dynamics in blood donors and COVID-19 epidemiology in eight Brazilian state capitals: A serial cross-sectional study.Elife. 2022 Sep 22;11:e78233. doi: 10.7554/eLife.78233. Elife. 2022. PMID: 36135358 Free PMC article.
-
Dynamics of SARS-CoV-2 infection over two epidemic waves in Manaus, Brazil: A serological study of seven thousand blood donors.PLoS One. 2025 Jan 15;20(1):e0308319. doi: 10.1371/journal.pone.0308319. eCollection 2025. PLoS One. 2025. PMID: 39813299 Free PMC article.
-
Screening for SARS-CoV-2 antibodies in convalescent plasma in Brazil: Preliminary lessons from a voluntary convalescent donor program.Transfusion. 2020 Dec;60(12):2938-2951. doi: 10.1111/trf.16065. Epub 2020 Sep 16. Transfusion. 2020. PMID: 32935877 Free PMC article.
Cited by
-
SARS-CoV-2 Variant of Concern 202012/01 Has about Twofold Replicative Advantage and Acquires Concerning Mutations.Viruses. 2021 Mar 1;13(3):392. doi: 10.3390/v13030392. Viruses. 2021. PMID: 33804556 Free PMC article.
-
Prevalence of SARS-CoV-2 antibodies after the Omicron surge, Kingston, Jamaica, 2022.J Clin Virol Plus. 2022 Nov;2(4):100124. doi: 10.1016/j.jcvp.2022.100124. Epub 2022 Nov 17. J Clin Virol Plus. 2022. PMID: 36415687 Free PMC article.
-
The Elecsys® Anti-SARS-CoV-2 and Elecsys® Anti-SARS-CoV-2 S antibody assays: Differentiating between vaccination and infection, and assessing long-term performance.PLoS One. 2024 Jul 18;19(7):e0305613. doi: 10.1371/journal.pone.0305613. eCollection 2024. PLoS One. 2024. PMID: 39024252 Free PMC article.
-
Spatial-temporal distribution of incidence, mortality, and case-fatality ratios of coronavirus disease 2019 and its social determinants in Brazilian municipalities.Sci Rep. 2023 Mar 13;13(1):4139. doi: 10.1038/s41598-023-31046-4. Sci Rep. 2023. PMID: 36914858 Free PMC article.
-
Outbreak.info genomic reports: scalable and dynamic surveillance of SARS-CoV-2 variants and mutations.Nat Methods. 2023 Apr;20(4):512-522. doi: 10.1038/s41592-023-01769-3. Epub 2023 Feb 23. Nat Methods. 2023. PMID: 36823332 Free PMC article.
References
-
- Hallal P. C., Hartwig F. P., Horta B. L., Silveira M. F., Struchiner C. J., Vidaletti L. P., Neumann N. A., Pellanda L. C., Dellagostin O. A., Burattini M. N., Victora G. D., Menezes A. M. B., Barros F. C., Barros A. J. D., Victora C. G., SARS-CoV-2 antibody prevalence in Brazil: Results from two successive nationwide serological household surveys. Lancet Glob. Health 8, e1390–e1398 (2020). 10.1016/S2214-109X(20)30387-9 - DOI - PMC - PubMed
-
- Candido D. da S., Claro I. M., de Jesus J. G., Souza W. M., Moreira F. R. R., Dellicour S., Mellan T. A., du Plessis L., Pereira R. H. M., Sales F. C. S., Manuli E. R., Thézé J., Almeida L., Menezes M. T., Voloch C. M., Fumagalli M. J., Coletti T. M., da Silva C. A. M., Ramundo M. S., Amorim M. R., Hoeltgebaum H. H., Mishra S., Gill M. S., Carvalho L. M., Buss L. F., Prete C. A., Ashworth J., Nakaya H. I., Peixoto P. S., Brady O. J., Nicholls S. M., Tanuri A., Rossi Á. D., Braga C. K. V., Gerber A. L., Guimarães A. P. de C., Gaburo N., Alencar C. S., Ferreira A. C. S., Lima C. X., Levi J. E., Granato C., Ferreira G. M., Francisco R. S., Granja F., Garcia M. T., Moretti M. L., Perroud M. W., Castiñeiras T. M. P. P., Lazari C. S., Hill S. C., de Souza-Santos A. A., Simeoni C. L., Forato J., Sposito A. C., Schreiber A. Z., Santos M. N. N., de Sá C. Z., Souza R. P., Resende-Moreira L. C., Teixeira M. M., Hubner J., Leme P. A. F., Moreira R. G., Nogueira M. L., Brazil-UK Centre for Arbovirus Discovery, Diagnosis, Genomics and Epidemiology (CADDE) Genomic Network, Ferguson N. M., Costa S. F., Proenca-Modena J. L., Vasconcelos A. T. R., Bhatt S., Lemey P., Wu C.-H., Rambaut A., Loman N. J., Aguiar R. S., Pybus O. G., Sabino E. C., Faria N. R., Evolution and epidemic spread of SARS-CoV-2 in Brazil. Science 369, 1255–1260 (2020). 10.1126/science.abd2161 - DOI - PMC - PubMed
-
- de Souza W. M., Buss L. F., Candido D. da S., Carrera J.-P., Li S., Zarebski A. E., Pereira R. H. M., Prete C. A. Jr.., de Souza-Santos A. A., Parag K. V., Belotti M. C. T. D., Vincenti-Gonzalez M. F., Messina J., da Silva Sales F. C., Andrade P. D. S., Nascimento V. H., Ghilardi F., Abade L., Gutierrez B., Kraemer M. U. G., Braga C. K. V., Aguiar R. S., Alexander N., Mayaud P., Brady O. J., Marcilio I., Gouveia N., Li G., Tami A., de Oliveira S. B., Porto V. B. G., Ganem F., de Almeida W. A. F., Fantinato F. F. S. T., Macário E. M., de Oliveira W. K., Nogueira M. L., Pybus O. G., Wu C.-H., Croda J., Sabino E. C., Faria N. R., Epidemiological and clinical characteristics of the COVID-19 epidemic in Brazil. Nat. Hum. Behav. 4, 856–865 (2020). 10.1038/s41562-020-0928-4 - DOI - PubMed
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous